FDA rejects Regenxbio’s rare-disease gene therapy - statnews.com

The Food and Drug Administration has rejected a rare-disease gene therapy from Regenxbio, the company said Monday.

Is the U.S. economy creating any jobs? Is inflation really slowing? Investors are about to find out. - MarketWatch

January employment report and CPI could set the stage for future Fed interest-rate cuts

Kyndryl Stock: How Earnings, Accounting, and a CEO Change Led to a 55% Plunge - Barron's

Hims Stock Crashes With Novo Lawsuit; But Novo Faces A Battle - Investor's Business Daily

Hims stock crashed Monday after Novo Nordisk filed a lawsuit, claiming the online pharmacy is “deceiving patients.”

Databricks CEO says SaaS isn’t dead, but AI will soon make it irrelevant - TechCrunch

AI isn’t going to replace major SaaS apps with vibe-coded versions, Databricks CEO Ali Ghodsi believes. But it could give rise to competitors.

Kroger Stock Takes Off After Appointing The Man Who Turned Walmart Around As CEO - Investor's Business Daily

Kroger stock advanced on Monday after announcing its new CEO is former Walmart executive Greg Foran.